Neos Therapeutics to Host First Quarter 2018 Financial Results Conference Call on May 9, 2018
02 mai 2018 07h30 HE
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, May 02, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results
15 mars 2018 07h00 HE
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, March 15, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Host Fourth Quarter and Year-End 2017 Financial Results Conference Call on March 15, 2017
08 mars 2018 07h30 HE
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, March 08, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Present at the Cowen & Co. Annual Health Care Conference
05 mars 2018 08h00 HE
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, March 05, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics Launches Adzenys ER™ (amphetamine) Extended-Release Oral Suspension in U.S. for the Treatment of ADHD in Patients 6 Years and Older
26 févr. 2018 08h00 HE
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Feb. 26, 2018 (GLOBE NEWSWIRE) --
Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing...
Neos Therapeutics to Present Three Posters at the Upcoming American Professional Society of ADHD and Related Disorders (APSARD) Annual Meeting
10 janv. 2018 08h00 HE
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative...
Neos Therapeutics to Participate in Two December Conferences
28 nov. 2017 08h00 HE
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative...
Neos Therapeutics Reports Third Quarter 2017 Financial Results
08 nov. 2017 07h00 HE
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Present at the Stifel 2017 Healthcare Conference
07 nov. 2017 08h00 HE
|
Neos Therapeutics, Inc.
DALLAS/FORT WORTH, Texas, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative...
Neos Therapeutics to Host Third Quarter 2017 Financial Results Conference Call on November 8, 2017
02 nov. 2017 08h00 HE
|
Neos Therapeutics, Inc.
DALLAS/FORT WORTH, Texas, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...